Active Ingredient: RIFAMPIN
Proprietary Name: RIFAMPIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 600MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A206736
Product Number: 001
Approval Date: Jan 19, 2016
Applicant Holder Full Name: WATSON PHARMACEUTICALS INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information